NCT02753569View on ClinicalTrials.gov

Imaging NSCLC Treatment Response to Immunotherapy

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 14, 2020

Study Completion Date

May 14, 2020

Conditions
Cancer
Interventions
OTHER

Imaging - DW-MRI

RADIATION

FDG PET-CT

Trial Locations (1)

SM2 5PT

The Royal Marsden NHS Foundation Trust, Sutton

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Royal Marsden NHS Foundation Trust

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER

NCT02753569 - Imaging NSCLC Treatment Response to Immunotherapy | Biotech Hunter | Biotech Hunter